123 related articles for article (PubMed ID: 8570515)
1. Methodologies for pharmaceutical effectiveness and pharmacoeconomics research.
Gable CB
Pharm Res; 1995 Sep; 12(9):1248-9. PubMed ID: 8570515
[No Abstract] [Full Text] [Related]
2. Pharmacoeconomics, Outcomes Research, Health Technology Assessment, Comparative Effectiveness, Patient Centered Outcomes Research in Latin America 2016: brief update.
Augustovski F; Caro J; Ferraz MB; Zárate V
Value Health Reg Issues; 2016 Dec; 11():74-75. PubMed ID: 27986202
[No Abstract] [Full Text] [Related]
3. Pharmacoeconomics: integrating economic evaluation into clinical trials.
Haycox A; Drummond M; Walley T
Br J Clin Pharmacol; 1997 Jun; 43(6):559-62. PubMed ID: 9205814
[No Abstract] [Full Text] [Related]
4. Why we need outcomes research and pharmacoeconomics in pain management and palliative care.
Lipman AG
J Pain Palliat Care Pharmacother; 2002; 16(3):1-3. PubMed ID: 14640351
[No Abstract] [Full Text] [Related]
5. Observational studies and "real world" anesthesia pharmacoeconomics.
Miller DR; Tierney M
Can J Anaesth; 2002 Apr; 49(4):329-34. PubMed ID: 11927469
[No Abstract] [Full Text] [Related]
6. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 9.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 Nov; 11(16):1147-1149. PubMed ID: 35998008
[TBL] [Abstract][Full Text] [Related]
7. Establishing value through pharmacoeconomics: the emerging third objective in clinical trials.
Boyer JG; Pathak DS
Top Hosp Pharm Manage; 1994 Jan; 13(4):1-10. PubMed ID: 10130679
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoeconomics and managed care: methodologic and policy issues.
Luce BR
Med Decis Making; 1998; 18(2 Suppl):S4-11. PubMed ID: 9566461
[No Abstract] [Full Text] [Related]
9. Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide.
Stahl JE
Pharmacoeconomics; 2008; 26(2):131-48. PubMed ID: 18198933
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomics and outcomes research.
Bootman JL
Am J Health Syst Pharm; 1995 Jul; 52(14 Suppl 3):S16-9. PubMed ID: 7552912
[No Abstract] [Full Text] [Related]
11. Overview of pharmacoeconomics and pharmaceutical outcomes evaluations.
Reeder CE
Am J Health Syst Pharm; 1995 Oct; 52(19 Suppl 4):S5-8. PubMed ID: 8846244
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoeconomics.
Ahuja J; Gupta M; Gupta AK; Kohli K
Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
[TBL] [Abstract][Full Text] [Related]
13. [Educational standards of the Polish Pharmacoeconomic Society].
Czech M; Hermanowski T; Kocić I; Lis J; Nowakowska E;
Pol Merkur Lekarski; 2009 Nov; 27(161):400-3. PubMed ID: 19999805
[TBL] [Abstract][Full Text] [Related]
14. Commentary: pharmacoeconomics and outcomes research: expanding the healthcare "outcomes" market.
Hay JW; Yu WM
Value Health; 2000; 3(3):181-5. PubMed ID: 16464182
[No Abstract] [Full Text] [Related]
15. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.
Ramsey S; Willke R; Briggs A; Brown R; Buxton M; Chawla A; Cook J; Glick H; Liljas B; Petitti D; Reed S
Value Health; 2005; 8(5):521-33. PubMed ID: 16176491
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness as an outcome in randomized clinical trials.
Hlatky MA; Owens DK; Sanders GD
Clin Trials; 2006; 3(6):543-51. PubMed ID: 17170039
[TBL] [Abstract][Full Text] [Related]
17. Drug therapy: safety, effectiveness, and economics.
Brandys J
Przegl Lek; 2001; 58(4):226-8. PubMed ID: 11450340
[TBL] [Abstract][Full Text] [Related]
18. Value-Based Pricing in Latin America: How Far Away Are We?
Mejía A; Gilardino R; Kristensen FB; Garrison LP;
Value Health Reg Issues; 2018 Dec; 17():219-223. PubMed ID: 30528780
[TBL] [Abstract][Full Text] [Related]
19. A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics.
Garattini L; Grilli R; Scopelliti D; Mantovani L
Pharmacoeconomics; 1995 Jan; 7(1):1-6. PubMed ID: 10155289
[No Abstract] [Full Text] [Related]
20. Pharmaceutical pricing conundrum: time to get rid of it?
Garattini L; Padula A
Eur J Health Econ; 2018 Nov; 19(8):1035-1038. PubMed ID: 30030646
[No Abstract] [Full Text] [Related]
[Next] [New Search]
